Evidence map›Paper›PMID 30970822›Full record

ArticlePolymers2017

Influence of Defined Hydrophilic Blocks within Oligoaminoamide Copolymers: Compaction versus Shielding of pDNA Nanoparticles.

Stephan Morys, Ana Krhac Levacic, Sarah Urnauer, Susanne Kempter, Sarah Kern, Joachim O Rädler, Christine Spitzweg, Ulrich Lächelt, Ernst Wagner

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stephan MorysDepartment of Pharmacy, Pharmaceutical Biotechnology, Ludwig-Maximilians-Universität München, 81377 München, Germany. stephan.morys@cup.uni-muenchen.de.
Ana Krhac LevacicDepartment of Pharmacy, Pharmaceutical Biotechnology, Ludwig-Maximilians-Universität München, 81377 München, Germany. ana.levacic@cup.uni-muenchen.de.
Sarah UrnauerDepartment of Internal Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, 81377 München, Germany. sarah.urnauer@med.uni-muenchen.de.
Susanne KempterDepartment of Physics, Ludwig-Maximilians-Universität München, 80799 München, Germany. susanne.kempter@physik.lmu.de.
Sarah KernDepartment of Pharmacy, Pharmaceutical Biotechnology, Ludwig-Maximilians-Universität München, 81377 München, Germany. sarah.kern@cup.uni-muenchen.de.
Joachim O RädlerDepartment of Physics, and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, 80799 München, Germany. raedler@lmu.de.
Christine SpitzwegDepartment of Internal Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, 81377 München, Germany. christine.spitzweg@med.uni-muenchen.de.
Ulrich LächeltDepartment of Pharmacy, Pharmaceutical Biotechnology, and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, 81377 München, Germany. ulrich.laechelt@cup.uni-muenchen.de.
Ernst WagnerDepartment of Pharmacy, Pharmaceutical Biotechnology, and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, 81377 München, Germany. ernst.wagner@cup.uni-muenchen.de.ORCID 0000-0001-8413-0934
Ludwig-Maximilians-Universität München · DECenter for NanoScience · DE

Funding

DFG excellence cluster Nanosystems Initiative MunichDFG Priority Programme SPP1629 SP 581/6-1, SP581/6-2DFG SFB 824 C8Sino-German Center GZ995Wilhelm-Sander-Stiftung 2014.129.1
6 · The paper itself

Abstract

Cationic polymers are promising components of the versatile platform of non-viral nucleic acid (NA) delivery agents. For a successful gene delivery system, these NA vehicles need to comprise several functionalities. This work focuses on the modification of oligoaminoamide carriers with hydrophilic oligomer blocks mediating nanoparticle shielding potential, which is necessary to prevent aggregation or dissociation of NA polyplexes in vitro, and hinder opsonization with blood components in vivo. Herein, the shielding agent polyethylene glycol (PEG) in three defined lengths (12, 24, or 48 oxyethylene repeats) is compared with two peptidic shielding blocks composed of four or eight repeats of sequential proline-alanine-serine (PAS). With both types of shielding agents, we found opposing effects of the length of hydrophilic segments on shielding and compaction of formed plasmid DNA (pDNA) nanoparticles. Two-arm oligoaminoamides with 37 cationizable nitrogens linked to 12 oxyethylene units or four PAS repeats resulted in very compact 40⁻50 nm pDNA nanoparticles, whereas longer shielding molecules destabilize the investigated polyplexes. Thus, the balance between sufficiently shielded but still compact and stable particles can be considered a critical optimization parameter for non-viral nucleic acid vehicles based on hydrophilic-cationic block oligomers.

Indexed as

complex stabilitynanoparticlenucleic acid deliveryoligoamineplasmid DNA (pDNA)polyethylene glycol (PEG)polyplexshielding

Identifiers

PMID30970822
PMCPMC6432433
OpenAlexW2606930947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.